Wellmarker Bio (WMBIO), a Korean biomarker based anti-cancer drug development company and the Korea Institute of Radiological Medical Sciences (KIRAMS) had signed an MOU on February 27, 2019 for mutual cooperation on new drug development and technology commercialization.
Link: http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065747
Link: http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065747